Ghent University Hospital Chooses RayStation as Main Treatment Planning System
News Mar 12, 2016
With a capacity of more than 3,000 patients and nearly 6,000 employees, UZ Gent is one of the largest and most specialized hospitals in Flanders. Its radiation oncology department has a track record in the development of innovative radiation therapy delivery techniques. It greatly contributed to the development of IMRT and currently plays a leading role in clinical and physics research on dose painting by numbers.
UZ Gent radiation oncology department has a multivendor linac configuration from Elekta and Varian. The hospital needed treatment planning software that could easily integrate with their current systems and streamline their planning workflow. They found what they were looking for in the RayStation treatment planning software from RaySearch, which offers high compatibility with all linear accelerators commercially available. RayStation will be used for all of the hospital’s clinical treatment planning.
Prof. Dr. Yolande Lievens, Chair of the radiation oncology department, says: “With RayStation, we foresee the advantages of much quicker and more efficient daily planning that will allow us to choose the optimal plan for each individual patient. We also appreciate the openness of RaySearch toward the planning research performed in our department and the company’s enthusiasm in relation to potential collaboration.”
“We are extremely proud to count UZ Gent among our RayStation users. Their recognized expertise in radiation oncology will be highly valuable to further demonstrate the treatment planning system’s leading capabilities here in the Benelux region and we look forward to a fruitful collaboration,” says Annelies Zimmermann, Business Director of RaySearch Benelux.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.